Meridian Management Co. decreased its position in Monsanto (NYSE:MON) by 1.8% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 24,211 shares of the basic materials company’s stock after selling 435 shares during the quarter. Monsanto accounts for approximately 1.3% of Meridian Management Co.’s holdings, making the stock its 19th biggest holding. Meridian Management Co.’s holdings in Monsanto were worth $2,827,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Meyer Handelman Co. grew its holdings in Monsanto by 0.6% during the 3rd quarter. Meyer Handelman Co. now owns 124,552 shares of the basic materials company’s stock worth $14,923,000 after acquiring an additional 706 shares during the last quarter. Toronto Dominion Bank grew its holdings in Monsanto by 6.3% during the 3rd quarter. Toronto Dominion Bank now owns 1,014,313 shares of the basic materials company’s stock worth $121,519,000 after acquiring an additional 59,750 shares during the last quarter. Amalgamated Bank grew its holdings in Monsanto by 2.0% during the 3rd quarter. Amalgamated Bank now owns 52,909 shares of the basic materials company’s stock worth $6,340,000 after acquiring an additional 1,022 shares during the last quarter. Janus Henderson Group PLC grew its holdings in Monsanto by 57.1% during the 3rd quarter. Janus Henderson Group PLC now owns 2,342,693 shares of the basic materials company’s stock worth $280,696,000 after acquiring an additional 851,369 shares during the last quarter. Finally, Oakbrook Investments LLC grew its holdings in Monsanto by 7.4% during the 3rd quarter. Oakbrook Investments LLC now owns 20,350 shares of the basic materials company’s stock worth $2,438,000 after acquiring an additional 1,400 shares during the last quarter. 75.62% of the stock is currently owned by institutional investors and hedge funds.
A number of brokerages have commented on MON. Wells Fargo & Co reissued a “market perform” rating and set a $128.00 price objective (up previously from $118.00) on shares of Monsanto in a report on Wednesday, January 17th. Deutsche Bank reissued a “buy” rating on shares of Monsanto in a report on Tuesday, January 16th. Zacks Investment Research lowered shares of Monsanto from a “buy” rating to a “hold” rating in a report on Monday, December 11th. Finally, Royal Bank of Canada reissued a “hold” rating and set a $128.00 price objective on shares of Monsanto in a report on Wednesday, November 15th. Eleven investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. The company has an average rating of “Hold” and an average target price of $127.30.
Monsanto (NYSE:MON) last released its earnings results on Thursday, January 4th. The basic materials company reported $0.41 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.42 by ($0.01). Monsanto had a net margin of 16.38% and a return on equity of 40.13%. The business had revenue of $2.66 billion for the quarter, compared to analyst estimates of $2.77 billion. During the same quarter in the previous year, the company posted $0.21 earnings per share. The business’s revenue for the quarter was up .3% on a year-over-year basis. equities research analysts anticipate that Monsanto will post 5.76 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, April 27th. Shareholders of record on Friday, April 6th will be given a dividend of $0.54 per share. The ex-dividend date of this dividend is Thursday, April 5th. This represents a $2.16 dividend on an annualized basis and a yield of 1.81%. Monsanto’s payout ratio is presently 39.85%.
In related news, EVP Steven Mizell sold 8,100 shares of the stock in a transaction that occurred on Tuesday, January 9th. The shares were sold at an average price of $119.35, for a total value of $966,735.00. Following the sale, the executive vice president now directly owns 56,743 shares in the company, valued at approximately $6,772,277.05. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.70% of the company’s stock.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto (NYSE:MON).
Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with MarketBeat.com's FREE daily email newsletter.